Jason Liu, MD

Thanks to @IJROBP & @sueyom for allowing me to share my #mentalhealth journey, "After #Burnout: Reigniting the Flame." I hope this essay can help others out there in medicine that might be struggling. sciencedirect.com/science/articl… #physicianburnout #anxiety #depression #wellness

Grateful for my work fam at @COH_RadOnc for throwing me and my wife the sweetest baby shower. Can’t ask for a better group of people to work with everyday. Expecting twin boys soon!

Physician Spotlight: @JasonRLiuMD is a COH trained rad onc at our South Pasadena network site. His office has recently implemented prone breast radiation and has treated >30 patients with osteoarthritis with LDRT. Clinical trials are also an option with a research nurse on staff!

@SeanPitroda @rweichselbaum @AndrasPiffko @IJROBP @NaturePortfolio @UChicago @UChicagoMed Thanks! Any explanation about how grid RT for bulky tumors can still have favorable local control and bystander effects without stimulating systemic tumor growth?

8/ Summary: Radiation doesn’t “spread cancer.” But biology is complex — and embracing that complexity helps us make SBRT even more effective. @rweichselbaum @AndrasPiffko Hua Laura Liang @SeanPitroda 📄 Authors’ View now in @IJROBP @NaturePortfolio @UChicago @UChicagoMed

1/ Our Nature paper on radiation-induced AREG sparked discussion - and some misinterpretation (nature.com/articles/s4158…). We clarify key points in our new Authors’ View in the Red Journal (@IJROBP). 🧵 Here’s what we actually found — and what we didn’t: sciencedirect.com/science/articl…

#astro25 @NRGonc Rtog 0924 trial on 2500 patients testing whole pelvic RT. Negative trial -OS no difference -PCSM no difference -DM no difference -BCR was not SS different with only 4% difference at 10 years. -toxicity increased 3 cooperative group trials now negative: getug01, Rtog 9413, Rtog 0924. Goodbye WPRT

@DrSpratticus @NRGonc Any subset analysis for just high risk pts? Don't think anyone does WPRT for intermediate risk pts. Thank you!

Colleagues recent experience submitting RCT to top tier journal This is ridiculous. Does it have to be so painful? Like everything in life, too much or too little (peer review in this case) is not good!

It’s out!!! 🔥🔥🔥 The PREOPANC-2 is in @TheLancetOncol Neoadjuvant FOLFIRINOX 🤜🤛 Gemcitabine based chemoradiotherapy in resecatble / BR ⚖️ No difference in overall survival 😰 Serious adverse events 40% 👍 Both regimens may be considered thelancet.com/journals/lanon…

We're proud to celebrate Robert Stone, CEO of @cityofhope, and @DrMvandenBrink, President of City of Hope Los Angeles and City of Hope National Medical Center, for being named to the @LABJnews 2025 LA500 list, honoring Los Angeles' most influential leaders. #LA500

🔥NSABP- B51 is out! Practice changing trial supporting RT de-escalation in cN1, ypN0 breast cancer 👉longer follow up desired 👉applicability across subtypes? 👉Impact of more modern systemic therapies ? @NRGonc @ASTRO_org #BreastCancer nejm.org/doi/full/10.10…

🚨 Wow! #ASCO25 @ASCO was absolutely massive! 10 @NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

❗️ Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer (ACHILES) HR 1.14 (0.76-1.71) 👎 and makes me wonder re: ADRIATIC as well 🤔 #ASCO25

@COH_RadOnc @DocGlaser Well deserved! One of the best educators in all of rad onc

We are excited to announce Dr. Scott Glaser in his new role as Residency Program Director. He is an excellent teacher, mentor, and incredibly committed to resident education. Congratulations on your new appointment.

@UCCancerCenter @Nature @rweichselbaum @AndrasPiffko @UChicagoRadonc Very interesting. Do you know how often this happens? Any idea if there are any patient/tumor specific variables that predict for amphiregulin expression?

🔥 Hot off the press: Ralph Weichselbaum, MD, and his team published a new study in @Nature demonstrating that high-dose radiation to primary tumors can unexpectedly promote tumor growth at metastatic sites. @rweichselbaum @AndrasPiffko @UChicagoRadonc uchicagomedicine.org/forefront/canc…

On this episode @DrEdKim & I dabble in discussions on his many contributions to #lungcancer, but go far beyond to discuss a holistic view of his approach to overseeing @cityofhope’s rapid expansion with research across #Chicago, #Atlanta & #Phoenix. I’ve known him as a tremendous leader during @cityofhopeoc’s inception - great to see the additional roles he is taking on at the institution. Pinging my esteemed thoracic colleagues & others to have a listen & offer their feedback! Available on @ApplePodcasts & @Spotify - spoti.fi/4hOfEJV @PatelOncology @StephenVLiu @HornLeora @VivekSubbiah @christine_lovly @DrJNaidoo @NarjustFlorezMD @DrRaviSalgia @LudaBazhenovaMD @peters_solange @DrRaviSalgia @ReckampK @DavidRSpigel @DrMarkAwad @AnaVManana @DrMvandenBrink @neerajaiims @PGrivasMDPhD @DrChoueiri @ASCO @AACR

Time’s running out! The deadline to vote in the @usnews #BestHospitals survey is March 23. Join @TeWilliamsMD and vote for @cityofhope! Learn more: cityofhope.org/top5

@COH_RadOnc Congrats Eemon and @tomiwaawobayiku!

We are thrilled to welcome out two new residents who will start Summer 2026, Eemon Tizpa from Washington State and Tomiwa Awobayiku from New York Institute of Technology! We are excited to add you to the City of Hope Radiation Oncology Family!

@cityofhope @usnews @montypal Survey link here! doximity.com/surveys/best_h…

Calling all board-certified oncologists! Make your voice heard in the @usnews rankings. Join @montypal in supporting City of Hope and select City of Hope Comprehensive Cancer Center in this year’s #BestHospitals survey. Learn more: cityofhope.org/top5